158 related articles for article (PubMed ID: 35982253)
1. Neuroprotective activity of selenium nanoparticles against the effect of amino acid enantiomers in Alzheimer's disease.
Vicente-Zurdo D; Rodríguez-Blázquez S; Gómez-Mejía E; Rosales-Conrado N; León-González ME; Madrid Y
Anal Bioanal Chem; 2022 Nov; 414(26):7573-7584. PubMed ID: 35982253
[TBL] [Abstract][Full Text] [Related]
2. Ability of selenium species to inhibit metal-induced Aβ aggregation involved in the development of Alzheimer's disease.
Vicente-Zurdo D; Romero-Sánchez I; Rosales-Conrado N; León-González ME; Madrid Y
Anal Bioanal Chem; 2020 Sep; 412(24):6485-6497. PubMed ID: 32322953
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity, uptake and accumulation of selenium nanoparticles and other selenium species in neuroblastoma cell lines related to Alzheimer's disease by using cytotoxicity assays, TEM and single cell-ICP-MS.
Vicente-Zurdo D; Gómez-Gómez B; Romero-Sánchez I; Rosales-Conrado N; León-González ME; Madrid Y
Anal Chim Acta; 2023 Apr; 1249():340949. PubMed ID: 36868776
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: Inhibiting amyloid β aggregation and reactive oxygen species formation properties.
Yang L; Wang W; Chen J; Wang N; Zheng G
J Biomed Mater Res A; 2018 Dec; 106(12):3034-3041. PubMed ID: 30295993
[TBL] [Abstract][Full Text] [Related]
5. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
6. Anti-amyloidogenic amphipathic arginine-dehydrophenylalanine spheres capped selenium nanoparticles as potent therapeutic moieties for Alzheimer's disease.
Kour A; Tiwari V; Aggarwal N; Sekhar Panda H; Kumar A; Tiwari S; Chauhan VS; Shukla S; Panda JJ
Nanoscale; 2023 Aug; 15(30):12748-12770. PubMed ID: 37477348
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antioxidant properties of chitosan and carboxymethyl chitosan-stabilized selenium nanoparticles.
Chen W; Li Y; Yang S; Yue L; Jiang Q; Xia W
Carbohydr Polym; 2015 Nov; 132():574-81. PubMed ID: 26256384
[TBL] [Abstract][Full Text] [Related]
8. Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review.
Vicente-Zurdo D; Rosales-Conrado N; León-González ME
Talanta; 2024 Mar; 269():125519. PubMed ID: 38086100
[TBL] [Abstract][Full Text] [Related]
9. Effect of Ovocystatin on Amyloid β 1-42 Aggregation-In Vitro Studies.
Stańczykiewicz B; Goszczyński TM; Migdał P; Piksa M; Pawlik K; Gburek J; Gołąb K; Konopska B; Zabłocka A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982505
[TBL] [Abstract][Full Text] [Related]
10. Preparation and antioxidant properties of selenium nanoparticles-loaded chitosan microspheres.
Bai K; Hong B; He J; Hong Z; Tan R
Int J Nanomedicine; 2017; 12():4527-4539. PubMed ID: 28684913
[TBL] [Abstract][Full Text] [Related]
11. d-Enantiomeric RTHLVFFARK-NH
Liu W; Dong X; Sun Y
ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant capacities of the selenium nanoparticles stabilized by chitosan.
Zhai X; Zhang C; Zhao G; Stoll S; Ren F; Leng X
J Nanobiotechnology; 2017 Jan; 15(1):4. PubMed ID: 28056992
[TBL] [Abstract][Full Text] [Related]
13. The Anti-Amyloidogenic Action of Doxycycline: A Molecular Dynamics Study on the Interaction with Aβ42.
Gautieri A; Beeg M; Gobbi M; Rigoldi F; Colombo L; Salmona M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546787
[TBL] [Abstract][Full Text] [Related]
14. Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles.
Han SH; Chang YJ; Jung ES; Kim JW; Na DL; Mook-Jung I
Int J Nanomedicine; 2010 Dec; 6():1-12. PubMed ID: 21289976
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol-Selenium Nanoparticles Alleviate Neuroinflammation and Neurotoxicity in a Rat Model of Alzheimer's Disease by Regulating Sirt1/miRNA-134/GSK3β Expression.
Abozaid OAR; Sallam MW; El-Sonbaty S; Aziza S; Emad B; Ahmed ESA
Biol Trace Elem Res; 2022 Dec; 200(12):5104-5114. PubMed ID: 35059981
[TBL] [Abstract][Full Text] [Related]
16. Studies on the role of amino acid stereospecificity in amyloid beta aggregation.
Gupta VB; Indi SS; Rao KS
J Mol Neurosci; 2008; 34(1):35-43. PubMed ID: 18157656
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of carbon quantum dots for application of alleviating amyloid-β mediated neurotoxicity.
Li H; Zhang Y; Ding J; Wu T; Cai S; Zhang W; Cai R; Chen C; Yang R
Colloids Surf B Biointerfaces; 2022 Apr; 212():112373. PubMed ID: 35101826
[TBL] [Abstract][Full Text] [Related]
18. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo.
Eriksen JL; Sagi SA; Smith TE; Weggen S; Das P; McLendon DC; Ozols VV; Jessing KW; Zavitz KH; Koo EH; Golde TE
J Clin Invest; 2003 Aug; 112(3):440-9. PubMed ID: 12897211
[TBL] [Abstract][Full Text] [Related]
19. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
Huo X; Zhang Y; Jin X; Li Y; Zhang L
J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Alzheimer's amyloid-β
Narang SS; Goyal D; Goyal B
J Biomol Struct Dyn; 2020 Apr; 38(6):1598-1611. PubMed ID: 31046642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
